Keywords: Genova, patent, prostate cancer

Genova files patent for new prostate cancer treatment

Article | 09 September 2009

GENova Biotherapeutics has filed a patent for a novel peptide that disrupts the advance of prostate cancer and thus has ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in